Private Placement

Seasoned banker Taso Carayannis joins Hamilton Reserve Bank, signaling a strategic move to blend Wall Street expertise with Caribbean fintech power.

An ambitious challenge aims to turn Amazon biodiversity into sustainable businesses, betting that entrepreneurship is the key to the rainforest's survival.

Global wealth manager AlTi Global is partnering with AI platform Nevis to automate workflows, empowering its advisors to focus on high-touch client service.

Dr. Amie Hornaman's bestseller, The Thyroid Fix, confronts medical gaslighting, empowering women to look beyond 'normal' lab results for answers.

SoundThinking hires Mark43 veteran David Jochim to lead its TechnoLogic division, signaling a strategic push for operational excellence and delivery.

As CPG startups face a funding crunch and retail hurdles, one operator-led platform is expanding its 'access-first' model nationwide. Here's why it matters.

A new six-month semaglutide implant is entering clinical trials, aiming to solve the adherence crisis plaguing GLP-1 drugs like Ozempic and Wegovy.

Aspen Midstream's new 3 Bcf/d Katy Hub will connect Texas gas supply to soaring LNG, power, and industrial demand, reshaping the Gulf Coast energy map.

A new benchmark shows top AI voice tools fail in non-English languages, challenging billion-dollar deployments and exposing deep-rooted linguistic bias.

A new strategic partnership aims to channel $1 billion into Oman, boosting its role as a key financial and industrial hub connecting Asia and the GCC.

A successful rocket launch and recovery proves space is the new frontier for delivering goods anywhere on Earth in minutes, shaking up global logistics and defense.

A new venture backed by Cerberus and Eos aims to fast-track U.S. energy storage with a novel model combining capital, tech, and insurance.

A $25M payment from partner Chiesi catapults Protalix to a profitable quarter, funding a promising new gout therapy and a broader rare disease strategy.

With a new CEO, a half-billion-dollar war chest, and a novel drug pipeline, Damora Therapeutics is making an aggressive play to redefine blood cancer treatment.

With a novel drug for schizophrenia and deep financial backing, LB Pharmaceuticals is advancing a promising new therapy for complex mental illnesses.

As BranchOut Food preps its Q1 earnings call, investors watch to see if its patented tech and retail wins can deliver on the path to profitability.

Response Pharmaceuticals unveils promising data on RDX-002, a first-in-class drug aimed at preventing a severe side effect of essential mental health drugs.

Amidst a quarterly loss, Coincheck inks a major deal with telco giant KDDI and expands into institutional ETFs, betting big on a diversified future.

Impulse Biomedical, a Cape Town startup, enters the US market via a Maryland program, bringing a reloadable epi-pen and an ergonomic inhaler sleeve.

Fueled by personal tragedy and backed by tech titans, a new foundation aims to revolutionize lung cancer detection using AI and genetics for non-smokers.